FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

929360071000036103: Medicinal product unit of use reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288211000168116 MPUU (medicinal product unit of use) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507151000036113 Medicinal product unit of use reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
965507161000036111 Medicinal product unit of use reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4351141000168117 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more equivalent Trade Product Units of Use.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


7425 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product unit of use reference set Developed by Australian Digital Health Agency true Inferred relationship Some 615170453
Medicinal product unit of use reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1364130978
Medicinal product unit of use reference set Is a Simple type reference set true Inferred relationship Some

Members
monobasic potassium phosphate 1.361 g (potassium 10 mmol)/10 mL injection, ampoule
monobasic potassium phosphate 1.361 g (potassium 10 mmol)/10 mL injection, vial
montelukast 10 mg tablet
montelukast 4 mg chewable tablet
montelukast 4 mg granules, 4 g sachet
montelukast 5 mg chewable tablet
moroctocog alfa 1000 units injection, chamber
moroctocog alfa 1000 international units injection, 1000 international units vial (medicinal product unit of use)
moroctocog alfa 2000 units injection, chamber
moroctocog alfa 2000 units injection, vial
moroctocog alfa 250 units injection, chamber
moroctocog alfa 250 units injection, vial
moroctocog alfa 3000 units injection, chamber
moroctocog alfa 500 units injection, chamber
moroctocog alfa 500 units injection, vial
morphine hydrochloride 2 mg/mL oral liquid
morphine hydrochloride trihydrate 1 mg/mL oral liquid
morphine hydrochloride trihydrate 10 mg/mL injection, ampoule
morphine hydrochloride trihydrate 10 mg/mL oral liquid
morphine hydrochloride trihydrate 100 mg/5 mL injection, ampoule
morphine hydrochloride trihydrate 2 mg/mL oral liquid
morphine hydrochloride trihydrate 20 mg/mL injection, ampoule
morphine hydrochloride trihydrate 20 mg/mL oral liquid
morphine hydrochloride trihydrate 200 microgram/mL intrathecal injection, vial
morphine hydrochloride trihydrate 40 mg/mL oral liquid
morphine hydrochloride trihydrate 5 mg/mL oral liquid
morphine hydrochloride trihydrate 50 mg/5 mL injection, ampoule
morphine hydrochloride trihydrate 500 microgram/mL intrathecal injection, vial
morphine sulfate pentahydrate 10 mg/mL injection, ampoule
morphine sulfate pentahydrate 10 mg/mL modified release injection, vial
morphine sulfate pentahydrate 10 mg modified release capsule
morphine sulfate pentahydrate 10 mg modified release tablet
morphine sulfate pentahydrate 10 mg tablet
morphine sulfate pentahydrate 100 mg modified release capsule
morphine sulfate pentahydrate 100 mg modified release granules, 1 sachet
morphine sulfate pentahydrate 100 mg modified release tablet
morphine sulfate pentahydrate 120 mg modified release capsule
morphine sulfate pentahydrate 15 mg/mL injection, ampoule
morphine sulfate pentahydrate 15 mg modified release tablet
morphine sulfate pentahydrate 2 mg/mL injection, ampoule
morphine sulfate pentahydrate 20 mg modified release capsule
morphine sulfate pentahydrate 20 mg modified release granules, 1 sachet
morphine sulfate pentahydrate 20 mg tablet
morphine sulfate pentahydrate 200 mg modified release granules, 1 sachet
morphine sulfate pentahydrate 200 mg modified release tablet
morphine sulfate pentahydrate 30 mg/mL injection, ampoule
morphine sulfate pentahydrate 30 mg modified release capsule
morphine sulfate pentahydrate 30 mg modified release granules, 1 sachet
morphine sulfate pentahydrate 30 mg modified release tablet
morphine sulfate pentahydrate 30 mg tablet
morphine sulfate pentahydrate 5 mg/mL injection, ampoule
morphine sulfate pentahydrate 5 mg modified release tablet
morphine sulfate pentahydrate 50 mg/5 mL injection, ampoule
morphine sulfate pentahydrate 50 mg modified release capsule
morphine sulfate pentahydrate 60 mg modified release capsule
morphine sulfate pentahydrate 60 mg modified release granules, 1 sachet
morphine sulfate pentahydrate 60 mg modified release tablet
morphine sulfate pentahydrate 90 mg modified release capsule
morphine tartrate 120 mg/1.5 mL injection, ampoule
morphine tartrate 400 mg/5 mL injection, ampoule
moxifloxacin 400 mg/250 mL injection, bag
moxifloxacin 400 mg/250 mL injection, bottle
moxifloxacin 400 mg tablet
moxonidine 200 microgram tablet
moxonidine 300 microgram tablet
moxonidine 400 microgram tablet
mupirocin 2% cream
mupirocin 2% ointment
muromonab-CD3 5 mg/5 mL injection, ampoule
mycophenolate 180 mg enteric tablet
mycophenolate 360 mg enteric tablet
mycophenolate mofetil 1 g/5 mL powder for oral liquid
mycophenolate mofetil 250 mg capsule
mycophenolate mofetil 500 mg injection, vial
mycophenolate mofetil 500 mg tablet
nabiximols 80 mg/mL spray, actuation
nadolol 40 mg tablet
nadroparin calcium 11 400 anti-Xa units/0.6 mL injection, syringe
nadroparin calcium 15 200 anti-Xa units/0.8 mL injection, syringe
nadroparin calcium 1900 anti-Xa units/0.2 mL injection, syringe
nadroparin calcium 19 000 anti-Xa units/mL injection, syringe
nadroparin calcium 2850 anti-Xa units/0.3 mL injection, syringe
nadroparin calcium 3800 anti-Xa units/0.4 mL injection, syringe
nadroparin calcium 5700 anti-Xa units/0.6 mL injection, syringe
nadroparin calcium 7600 anti-Xa units/0.8 mL injection, syringe
nadroparin calcium 9500 anti-Xa units/mL injection, syringe
nafarelin 200 microgram/actuation nasal spray, actuation
naloxegol 12.5 mg tablet
naloxegol 25 mg tablet
naloxone 1.8 mg/actuation nasal spray, actuation
naloxone hydrochloride 1 mg/mL injection, syringe
oxycodone hydrochloride 2.5 mg + naloxone hydrochloride 1.25 mg modified release tablet
oxycodone hydrochloride 20 mg + naloxone hydrochloride 10 mg modified release tablet
oxycodone hydrochloride 30 mg + naloxone hydrochloride 15 mg modified release tablet
naloxone hydrochloride 2 mg/5 mL injection, syringe
oxycodone hydrochloride 5 mg + naloxone hydrochloride 2.5 mg modified release tablet
oxycodone hydrochloride 40 mg + naloxone hydrochloride 20 mg modified release tablet
oxycodone hydrochloride 60 mg + naloxone hydrochloride 30 mg modified release tablet
oxycodone hydrochloride 80 mg + naloxone hydrochloride 40 mg modified release tablet
naloxone hydrochloride 40 microgram/2 mL injection, ampoule
naloxone hydrochloride 400 microgram/mL injection, ampoule

Start Previous Page 54 of 75 Next End


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start